| Followers | 18 |
| Posts | 1211 |
| Boards Moderated | 0 |
| Alias Born | 04/19/2012 |
Tuesday, January 15, 2013 6:47:49 AM
ACAD +12% on much higher than average volume. Read CN's post from JPM healthcare conference.
This is one of the pearls of the developemental biotechs. Has a real chance for approval in an unserved market worth 1B+ annually in sales.
This is one of the pearls of the developemental biotechs. Has a real chance for approval in an unserved market worth 1B+ annually in sales.
[img]/img]
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
